Shares of ASP Isotopes dropped 9% to $6.45, while Endra Life Sciences took a steeper hit, falling 38% to $3.87 following the announcement. The transaction involves merging ASP’s Noble Africa unit with an Endra subsidiary to form a new public entity, Noble Africa Inc., which intends to trade on the Nasdaq under the ticker NOBA.
In section Market Quotes
ASP Isotopes and Endra Life Sciences Slide on Merger News
Investors reacted sharply to a proposed merger between ASP Isotopes and Endra Life Sciences, sending share prices tumbling as the companies unveiled plans to consolidate their helium interests. The deal, which aims to unlock value from the Virginia Gas Project in South Africa, faces skepticism from the market.
To fund the development of the Virginia Gas Project, the firms are initiating a $50 million private placement, with ASP Isotopes acting as the lead investor by contributing $20 million. Under the current structure, ASP Isotopes would control roughly 89% of the resulting company, leaving existing Endra shareholders with approximately 3%. Chief Executive Paul Mann stated that the move provides investors with direct exposure to helium assets while securing the capital necessary for project advancement. The companies anticipate the deal will close between the third and fourth quarters of 2026, pending shareholder approval.
Comments (0)
No comments yet. Be the first!